Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN

Genes to Cells

Volumn 19, Issue 3, 2014, Pages 254-272

  Takiuchi, Tsuyoshi ^a,b   Nakagawa, Tomoko ^a   Tamiya, Hironari ^a,b   Fujita, Hiroaki ^a,c   Sasaki, Yoshiteru ^a   Saeki, Yasushi ^d   Takeda, Hiroyuki ^e   Sawasaki, Tatsuya ^e   Buchberger, Alexander ^f   Kimura, Tadashi ^b   Iwai, Kazuhiro ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e EHIME UNIVERSITY   (Japan)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOPEPTIDASES; HUMANS; NF-KAPPA B; PROTEIN SUBUNITS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; UBIQUITINATION; WNT SIGNALING PATHWAY;

EID: 84894496869     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12128     Document Type: Article

References (54)

1. Allen, M.D., Buchberger, A. & Bycroft, M. (2006) The PUB domain functions as a p97 binding module in human peptide N-glycanase. J. Biol. Chem. 281, 25502-25508.
2. Ben-Neriah, Y. & Karin, M. (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715-723.
3. Bertrand, M.J., Milutinovic, S., Dickson, K.M., Ho, W.C., Boudreault, A., Durkin, J., Gillard, J.W., Jaquith, J.B., Morris, S.J. & Barker, P.A. (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700.
4. Bignell, G.R., Warren, W., Seal, S. et al. (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160-165.
5. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. & Bernards, R. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801.
6. Buchberger, A. (2010) Control of ubiquitin conjugation by cdc48 and its cofactors. Subcell. Biochem. 54, 17-30.
7. Dai, R.M., Chen, E., Longo, D.L., Gorbea, C.M. & Li, C.C. (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IκBα and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IκBα. J. Biol. Chem. 273, 3562-3573.
8. Dai, R.M. & Li, C.C. (2001) Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 3, 740-744.
9. Doerks, T., Copley, R.R., Schultz, J., Ponting, C.P. & Bork, P. (2002) Systematic identification of novel protein domain families associated with nuclear functions. Genome Res. 12, 47-56.
10. Emmerich, C.H., Ordureau, A., Strickson, S., Arthur, J.S., Pedrioli, P.G., Komander, D. & Cohen, P. (2013) Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl Acad. Sci. USA 110, 15247-15252.
11. Fernandez-Saiz, V. & Buchberger, A. (2010) Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 11, 479-485.
12. Gerlach, B., Cordier, S.M., Schmukle, A.C. et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596.
13. Haas, T.L., Emmerich, C.H., Gerlach, B., Schmukle, A.C., Cordier, S.M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T., Koschny, R., Komander, D., Silke, J. & Walczak, H. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844.
14. Hershko, A. & Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
15. Ikeda, F., Deribe, Y.L., Skanland, S.S. et al. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641.
16. Iwai, K. (2012) Diverse ubiquitin signaling in NF-κB activation. Trends Cell Biol. 22, 355-364.
17. Jono, H., Lim, J.H., Chen, L.F., Xu, H., Trompouki, E., Pan, Z.K., Mosialos, G. & Li, J.D. (2004) NF-κB is essential for induction of CYLD, the negative regulator of NF-κB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279, 36171-36174.
18. Kensche, T., Tokunaga, F., Ikeda, F., Goto, E., Iwai, K. & Dikic, I. (2012) Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. J. Biol. Chem. 287, 23626-23634.
19. Keusekotten, K., Elliott, P.R., Glockner, L., Fiil, B.K., Damgaard, R.B., Kulathu, Y., Wauer, T., Hospenthal, M.K., Gyrd-Hansen, M., Krappmann, D., Hofmann, K. & Komander, D. (2013) OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312-1326.
20. Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. (2011) New insights into the mechanism of Wnt signaling pathway activation. Int. Rev. Cell Mol. Biol. 291, 21-71.
21. Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K. & Iwai, K. (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887.
22. Komander, D., Clague, M.J. & Urbe, S. (2009a) Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563.
23. Komander, D., Lord, C.J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A. & Barford, D. (2008) The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol. Cell 29, 451-464.
24. Komander, D., Reyes-Turcu, F., Licchesi, J.D., Odenwaelder, P., Wilkinson, K.D. & Barford, D. (2009b) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466-473.
25. Kondo, H., Rabouille, C., Newman, R., Levine, T.P., Pappin, D., Freemont, P. & Warren, G. (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature 388, 75-78.
26. Kornitzer, D. & Ciechanover, A. (2000) Modes of regulation of ubiquitin-mediated protein degradation. J. Cell. Physiol. 182, 1-11.
27. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. & Courtois, G. (2003) The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805.
28. Madsen, L., Seeger, M., Semple, C.A. & Hartmann-Petersen, R. (2009) New ATPase regulators-p97 goes to the PUB. Int. J. Biochem. Cell Biol. 41, 2380-2388.
29. Massoumi, R. (2010) Ubiquitin chain cleavage: CYLD at work. Trends Biochem. Sci. 35, 392-399.
30. Matsunaga, S., Matsuoka, K., Shimizu, K., Endo, Y. & Sawasaki, T. (2010) Biotinylated-sortase self-cleavage purification (BISOP) method for cell-free produced proteins. BMC Biotechnol. 10, 42.
31. Meyer, H., Bug, M. & Bremer, S. (2012) Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117-123.
32. Meyer, H.H., Shorter, J.G., Seemann, J., Pappin, D. & Warren, G. (2000) A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J. 19, 2181-2192.
33. Pasparakis, M. (2009) Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 9, 778-788.
34. Peng, J., Schwartz, D., Elias, J.E., Thoreen, C.C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D. & Gygi, S.P. (2003) A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21, 921-926.
35. Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., Randow, F., Wakatsuki, S. & Dikic, I. (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098-1109.
36. Rivkin, E., Almeida, S.M., Ceccarelli, D.F., Juang, Y.C., MacLean, T.A., Srikumar, T., Huang, H., Dunham, W.H., Fukumura, R., Xie, G., Gondo, Y., Raught, B., Gingras, A.C., Sicheri, F. & Cordes, S.P. (2013) The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318-324.
37. Rumpf, S. & Jentsch, S. (2006) Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 21, 261-269.
38. Sasaki, Y., Sano, S., Nakahara, M., Murata, S., Kometani, K., Aiba, Y., Sakamoto, S., Watanabe, Y., Tanaka, K., Kurosaki, T. & Iwai, K. (2013) Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 32, 2463-2476.
39. Sun, S.C. (2010) CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ. 17, 25-34.
40. Suzuki, T., Park, H., Till, E.A. & Lennarz, W.J. (2001) The PUB domain: a putative protein-protein interaction domain implicated in the ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 287, 1083-1087.
41. Tauriello, D.V., Haegebarth, A., Kuper, I., Edelmann, M.J., Henraat, M., Canninga-van Dijk, M.R., Kessler, B.M., Clevers, H. & Maurice, M.M. (2010) Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol. Cell 37, 607-619.
42. Tokunaga, F. (2013) Linear ubiquitination-mediated NF-κB regulation and its related disorders. J. Biochem. 154, 313-323.
43. Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S., Tanaka, K., Nakano, H. & Iwai, K. (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636.
44. Tokunaga, F., Nishimasu, H., Ishitani, R., Goto, E., Noguchi, T., Mio, K., Kamei, K., Ma, A., Iwai, K. & Nureki, O. (2012) Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J. 31, 3856-3870.
45. Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., Yamamoto, M., Akira, S., Takao, T., Tanaka, K. & Iwai, K. (2009) Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123-132.
46. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. & Mosialos, G. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793-796.
47. Uchiyama, K., Jokitalo, E., Kano, F., Murata, M., Zhang, X., Canas, B., Newman, R., Rabouille, C., Pappin, D., Freemont, P. & Kondo, H. (2002) VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J. Cell Biol. 159, 855-866.
48. Vallabhapurapu, S. & Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
49. Walczak, H. (2011) TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol. Rev. 244, 9-28.
50. Wang, Q., Li, L. & Ye, Y. (2006) Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J. Cell Biol. 174, 963-971.
51. Yamamoto, H., Sakane, H., Michiue, T. & Kikuchi, A. (2008) Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling. Dev. Cell 15, 37-48.
52. Yamamoto, M., Okamoto, T., Takeda, K., Sato, S., Sanjo, H., Uematsu, S., Saitoh, T., Yamamoto, N., Sakurai, H., Ishii, K.J., Yamaoka, S., Kawai, T., Matsuura, Y., Takeuchi, O. & Akira, S. (2006) Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970.
53. Yeung, H.O., Kloppsteck, P., Niwa, H., Isaacson, R.L., Matthews, S., Zhang, X. & Freemont, P.S. (2008) Insights into adaptor binding to the AAA protein p97. Biochem. Soc. Trans. 36, 62-67.
54. Zhao, G., Zhou, X., Wang, L., Li, G., Schindelin, H. & Lennarz, W.J. (2007) Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc. Natl Acad. Sci. USA 104, 8785-8790.